ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells
Oncotarget - United States
doi 10.18632/oncotarget.12878
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 25, 2016
Authors
Publisher
Impact Journals, LLC